ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 683,65
-0,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) Actualités

VRDN Viridian Therapeutics Inc

16,30
1,72 (11,80%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Viridian Therapeutics Inc VRDN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,72 11,80% 16,30 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
15,08 15,01 15,50 15,40 14,58
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202414:00BWViridian Therapeutics Announces Inducement Grants Under..
29/4/202414:00BWViridian Therapeutics to Webcast First Quarter 2024..
04/4/202422:01BWViridian Therapeutics Announces Inducement Grants Under..
06/3/202422:01BWViridian Therapeutics Announces Inducement Grants Under..
05/3/202414:00BWViridian Therapeutics to Participate in the Leerink Partners..
28/2/202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:07EDGAR2Form 8-K - Current report
27/2/202422:01BWViridian Therapeutics Highlights Recent Progress and Reports..
16/2/202414:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
15/2/202402:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:01BWViridian Therapeutics Announces Inducement Grant Under..
25/1/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:12EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202423:22EDGAR2Form 8-K - Current report
19/1/202422:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/1/202404:00BWViridian Therapeutics Announces Pricing of Public Offering..
17/1/202422:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202422:01BWViridian Therapeutics Announces Proposed Underwritten Public..
12/1/202422:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202414:08EDGAR2Form 8-K - Current report
08/1/202414:00BWViridian Therapeutics to Present Key 2024 Corporate..
04/1/202414:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
18/12/202317:45EDGAR2Form 144 - Report of proposed sale of securities
18/12/202314:15EDGAR2Form 8-K - Current report
18/12/202313:00BWViridian Therapeutics Announces Positive Clinical Data in..
12/12/202322:19EDGAR2Form 144 - Report of proposed sale of securities
08/12/202322:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/12/202322:22EDGAR2Form 144 - Report of proposed sale of securities
01/12/202322:04EDGAR2Form 144 - Report of proposed sale of securities
30/11/202322:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
21/11/202314:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
13/11/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
08/11/202314:00BWViridian Therapeutics to Participate in the Jefferies London..
03/11/202321:30EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202313:00BWViridian Therapeutics Announces Encore Presentations at the..
02/11/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202321:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202313:35EDGAR2Form 8-K - Current report
30/10/202313:30BWViridian Therapeutics Appoints New Chief Executive Officer,..

Dernières Valeurs Consultées

NASDAQ
VRDN
Viridian Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés